EPROSARTAN

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Details

Stereochemistry	ACHIRAL
Molecular Formula	C23H24N2O4S
Molecular Weight	424.513
Optical Activity	NONE
Defined Stereocenters	0 / 0
E/Z Centers	1
Charge	0

SHOW SMILES / InChI

Structure of EPROSARTAN

Structure Search

SMILES

CCCCC1=NC=C(\C=C(/CC2=CC=CS2)C(O)=O)N1CC3=CC=C(C=C3)C(O)=O

InChI

InChIKey=OROAFUQRIXKEMV-LDADJPATSA-N

InChI=1S/C23H24N2O4S/c1-2-3-6-21-24-14-19(12-18(23(28)29)13-20-5-4-11-30-20)25(21)15-16-7-9-17(10-8-16)22(26)27/h4-5,7-12,14H,2-3,6,13,15H2,1H3,(H,26,27)(H,28,29)/b18-12+

HIDE SMILES / InChI

Molecular Formula	C23H24N2O4S
Molecular Weight	424.513
Charge	0
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	1
Optical Activity	NONE

Approval Year

Substance Class	Chemical Created by `admin` on `Fri Dec 15 16:37:23 UTC 2023` Edited by `admin` on `Fri Dec 15 16:37:23 UTC 2023`
Record UNII	2KH13Z0S0Y
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

EPROSARTAN

Official Name

English

SK&F-108566

Code

English

EPROSARTAN [MI]

Common Name

English

EPROSARTAN [USAN]

Common Name

English

2-THIOPHENEPROPANOIC ACID, .ALPHA.-((2-BUTYL-1-((4-CARBOXYPHENYL)METHYL)-LH-IMIDAZOL-5-YL)METHYLENE)-, (E)-

Common Name

English

Eprosartan [WHO-DD]

Common Name

English

eprosartan [INN]

Common Name

English

EPROSARTAN [VANDF]

Common Name

English

EPROSARTAN [HSDB]

Common Name

English

SK&F 108566

Code

English

(E)-2-BUTYL-1-(P-CARBOXYBENZYL)-.ALPHA.-2-THENYLIMIDAZOLE-5-ACRYLIC ACID

Common Name

English

Classification Tree Code System Code

NDF-RT

N0000175561

Created by admin on Fri Dec 15 16:37:23 UTC 2023 , Edited by admin on Fri Dec 15 16:37:23 UTC 2023

NCI_THESAURUS

C66930

Created by admin on Fri Dec 15 16:37:23 UTC 2023 , Edited by admin on Fri Dec 15 16:37:23 UTC 2023

WHO-VATC

QC09DA02

Created by admin on Fri Dec 15 16:37:23 UTC 2023 , Edited by admin on Fri Dec 15 16:37:23 UTC 2023

WHO-VATC

QC09CA02

Created by admin on Fri Dec 15 16:37:23 UTC 2023 , Edited by admin on Fri Dec 15 16:37:23 UTC 2023

LIVERTOX

NBK548507

Created by admin on Fri Dec 15 16:37:23 UTC 2023 , Edited by admin on Fri Dec 15 16:37:23 UTC 2023

WHO-ATC

C09DA02

Created by admin on Fri Dec 15 16:37:23 UTC 2023 , Edited by admin on Fri Dec 15 16:37:23 UTC 2023

WHO-ATC

C09CA02

Created by admin on Fri Dec 15 16:37:23 UTC 2023 , Edited by admin on Fri Dec 15 16:37:23 UTC 2023

NDF-RT

N0000000070

Created by admin on Fri Dec 15 16:37:23 UTC 2023 , Edited by admin on Fri Dec 15 16:37:23 UTC 2023

Code System Code Type Description

MESH

C068373

Created by admin on Fri Dec 15 16:37:23 UTC 2023 , Edited by admin on Fri Dec 15 16:37:23 UTC 2023

PRIMARY

INN

7223

Created by admin on Fri Dec 15 16:37:23 UTC 2023 , Edited by admin on Fri Dec 15 16:37:23 UTC 2023

PRIMARY

NCI_THESAURUS

C61749

Created by admin on Fri Dec 15 16:37:23 UTC 2023 , Edited by admin on Fri Dec 15 16:37:23 UTC 2023

PRIMARY

WIKIPEDIA

EPROSARTAN

Created by admin on Fri Dec 15 16:37:23 UTC 2023 , Edited by admin on Fri Dec 15 16:37:23 UTC 2023

PRIMARY

ChEMBL

CHEMBL813

Created by admin on Fri Dec 15 16:37:23 UTC 2023 , Edited by admin on Fri Dec 15 16:37:23 UTC 2023

PRIMARY

EVMPD

SUB06586MIG

Created by admin on Fri Dec 15 16:37:23 UTC 2023 , Edited by admin on Fri Dec 15 16:37:23 UTC 2023

PRIMARY

USAN

FF-70

Created by admin on Fri Dec 15 16:37:23 UTC 2023 , Edited by admin on Fri Dec 15 16:37:23 UTC 2023

PRIMARY

HSDB

7521

Created by admin on Fri Dec 15 16:37:23 UTC 2023 , Edited by admin on Fri Dec 15 16:37:23 UTC 2023

PRIMARY

RXCUI

83515

Created by admin on Fri Dec 15 16:37:23 UTC 2023 , Edited by admin on Fri Dec 15 16:37:23 UTC 2023

PRIMARY

RxNorm

IUPHAR

588

Created by admin on Fri Dec 15 16:37:23 UTC 2023 , Edited by admin on Fri Dec 15 16:37:23 UTC 2023

PRIMARY

DRUG BANK

DB00876

Created by admin on Fri Dec 15 16:37:23 UTC 2023 , Edited by admin on Fri Dec 15 16:37:23 UTC 2023

PRIMARY

CHEBI

4814

Created by admin on Fri Dec 15 16:37:23 UTC 2023 , Edited by admin on Fri Dec 15 16:37:23 UTC 2023

PRIMARY

DRUG CENTRAL

1037

Created by admin on Fri Dec 15 16:37:23 UTC 2023 , Edited by admin on Fri Dec 15 16:37:23 UTC 2023

PRIMARY

SMS_ID

100000084574

Created by admin on Fri Dec 15 16:37:23 UTC 2023 , Edited by admin on Fri Dec 15 16:37:23 UTC 2023

PRIMARY

LACTMED

Eprosartan

Created by admin on Fri Dec 15 16:37:23 UTC 2023 , Edited by admin on Fri Dec 15 16:37:23 UTC 2023

PRIMARY

PUBCHEM

5281037

Created by admin on Fri Dec 15 16:37:23 UTC 2023 , Edited by admin on Fri Dec 15 16:37:23 UTC 2023

PRIMARY

FDA UNII

2KH13Z0S0Y

Created by admin on Fri Dec 15 16:37:23 UTC 2023 , Edited by admin on Fri Dec 15 16:37:23 UTC 2023

PRIMARY

CAS

133040-01-4

Created by admin on Fri Dec 15 16:37:23 UTC 2023 , Edited by admin on Fri Dec 15 16:37:23 UTC 2023

PRIMARY

DAILYMED

2KH13Z0S0Y

Created by admin on Fri Dec 15 16:37:23 UTC 2023 , Edited by admin on Fri Dec 15 16:37:23 UTC 2023

PRIMARY

EPA CompTox

DTXSID0022989

Created by admin on Fri Dec 15 16:37:23 UTC 2023 , Edited by admin on Fri Dec 15 16:37:23 UTC 2023

PRIMARY

MERCK INDEX

m4961

Created by admin on Fri Dec 15 16:37:23 UTC 2023 , Edited by admin on Fri Dec 15 16:37:23 UTC 2023

PRIMARY

Merck Index

Related Record Type Details


					6D53G0FD0Z

PLASMA PROTEIN FRACTION (HUMAN)

BINDER->LIGAND

Interaction Type:

BINDING

Amount:


					8N2L1NX8S3

EPROSARTAN MESYLATE

SALT/SOLVATE -> PARENT


					056QD38ZSG

TYPE-1 ANGIOTENSIN II RECEPTOR

TARGET -> INHIBITOR

Amount:

Related Record Type Details


					H81CGI9K6Z

BENZYL(METHYL)NITROSAMINE

IMPURITY -> PARENT

Comments:

Priority toxic pollutant.

Amount:


					3IQ78TTX1A

N-NITROSODIETHYLAMINE

IMPURITY -> PARENT

Comments:

Probable human carcinogen.

Amount:


					M43H21IO8R

N-NITROSODIMETHYLAMINE

IMPURITY GENOTOXIC->PARENT

Comments:

NDMA is an organic chemical that is in a family of potent carcinogens.

Amount:

Related Record Type Details


					2KH13Z0S0Y

ACTIVE MOIETY

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
Biological Half-life	PHARMACOKINETIC

Volume of Distribution	PHARMACOKINETIC